LTFS
PJP icon

Ladenburg Thalmann Financial Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$843K Sell
13,022
-1,006
-7% -$61.2K 0.01% 1404
2019
Q3 		$795K Sell
14,028
-554
-4% -$31.9K 0.01% 1399
2019
Q2 		$878K Buy
14,582
+3,402
+30% +$209K 0.01% 1316
2019
Q1 		$728K Sell
11,180
-700
-6% -$46K 0.01% 1406
2018
Q4 		$742K Sell
11,880
-41
-0.3% -$2.77K 0.01% 1244
2018
Q3 		$876K Sell
11,921
-1,406
-11% -$101K 0.01% 1211
2018
Q2 		$832K Hold
13,327
– – 0.01% 1181
2018
Q1 		$832K Buy
13,327
+440
+3% +$29K 0.01% 1181
2017
Q4 		$827K Sell
12,887
-473
-4% -$30.3K 0.01% 1191
2017
Q3 		$874K Buy
13,360
+2,429
+22% +$153K 0.01% 1076
2017
Q2 		$686K Sell
10,931
-1,916
-15% -$115K 0.01% 1184
2017
Q1 		$755K Sell
12,847
-6,540
-34% -$382K 0.01% 1051
2016
Q4 		$1.09M Sell
19,387
-2,877
-13% -$166K 0.02% 803
2016
Q3 		$1.37M Buy
22,264
+3,819
+21% +$250K 0.02% 634
2016
Q2 		$1.17M Sell
18,445
-283
-2% -$17.8K 0.02% 690
2016
Q1 		$1.13M Sell
18,728
-32,106
-63% -$1.96M 0.02% 647
2015
Q4 		$3.56M Sell
50,834
-1,630
-3% -$116K 0.07% 265
2015
Q3 		$3.48M Buy
52,464
+2,626
+5% +$204K 0.07% 264
2015
Q2 		$3.9M Sell
49,838
-1,184
-2% -$92.2K 0.07% 269
2015
Q1 		$3.9M Buy
51,022
+4,255
+9% +$313K 0.07% 266
2014
Q4 		$3.11M Buy
46,767
+35,067
+300% +$2.34M 0.07% 259
2014
Q3 		$744K Sell
11,700
-9,963
-46% -$615K 0.02% 624
2014
Q2 		$1.32M Sell
21,663
-10,450
-33% -$606K 0.04% 417
2014
Q1 		$1.82M Sell
32,113
-426
-1% -$24.2K 0.05% 288
2013
Q4 		$1.74M Buy
32,539
+20,974
+181% +$1.05M 0.05% 286
2013
Q3 		$492K Buy
11,565
+625
+6% +$28.5K 0.02% 671
2013
Q2 		$463K Buy
+10,940
New +$455K 0.02% 657

Other funds holding PJP

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Ladenburg Thalmann Financial Services's PJP Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Invesco Pharmaceuticals ETF (PJP) stake by 7.2% in Q4 2019, selling an estimated $61.2K and leaving 13,022 shares worth $843K. The position accounts for 0.01% of the portfolio, ranked #1404.

Ladenburg Thalmann Financial Services first reported a position in PJP in Q2 2013 and has held it in 27 quarters since. The position peaked at $3.9M in Q2 2015. 93 funds tracked by Wall St. Rank hold PJP as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 13,022 shares of Invesco Pharmaceuticals ETF worth $843K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 1,006 Invesco Pharmaceuticals ETF shares in Q4 2019, an estimated $61.2K.
  • Invesco Pharmaceuticals ETF made up 0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1404 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Invesco Pharmaceuticals ETF position peaked at $3.9M in Q2 2015.
  • 93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.